Psychedelics: Psilocybin, MDMA and Ketamine

Psychedelics: Psilocybin, MDMA and Ketamine in Psychiatry: the news, the names and what changed.

  • 18 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Psychedelics: Psilocybin, MDMA and Ketamine


seekingalpha.com > news > 4642676-johnson-and-johnson-contineum-depression-candidate-fails-phase-2

J&J/Contineum depression candidate fails in phase 2

23+ min ago   (18+ words) J&J’s JNJ-5120 (PIPE-307) missed its phase 2 MOONLIGHT-1 primary endpoint in major depressive disorder. Read more here....


wsau.com > 09/14/2026 > contineum-jjs-depression-drug-fails-to-meet-mid-stage-trial-goal

Contineum, J&J’s depression drug fails to meet mid-stage trial goal

35+ min ago   (209+ words) Sept 15 (Reuters) – Contineum Therapeutics said on Monday an experimental depression drug it developed with Johnson & Johnson failed to meet ​the main goal of a mid-stage ‌study. • The trial was testing the drug, JNJ-5120 or PIPE-307, in patients with major depressive disorder,…...


biotechdispatch.com.au > news > entropys-psychedelic-infusion-keeps-binge-eating-disorder-at-bay-three-months-after-treatment-en

Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends

17+ hour, 54+ min ago   (260+ words) Six patients who had lived with binge eating disorder for as long as two decades sat down for two infusions of an experimental psychedelic drug. Three months later, all of them were still doing better. Half of them had not…...


natlawreview.com > press-releases > definium-therapeutics-discuss-topline-results-phase-3-panorama-study

Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026

17+ hour, 36+ min ago   (484+ words) Definium Therapeutics to Discuss Topline Results from Phase 3 Pan The National Law Review Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026 Company to host webcast tomorrow at 8:00 a.m. EDT NEW YORK--(BUSINESS WIRE)…...


news-medical.net-medical.net

A study of ayahuasca users found a mental health pattern researchers cannot yet explain

17+ hour, 14+ min ago   (705+ words) Researchers compared first-time and experienced ayahuasca users to see how prior exposure relates to mood, stress, spirituality, substance use, and beliefs about consciousness. Close-up of Banisteriopsis Caapi vines, one of the Ayahuasca plants. Study: Prior ayahuasca experience is associated with…...


earth.com > science > psychedelic-drugs-brain-networks

Psychedelic drugs leave surprisingly different marks on the brain

23+ hour, 13+ min ago   (1012+ words) Rats given LSD, psilocybin or 2C-B showed three different brain patterns, and the psychedelic drugs still differed a week later. Psychedelic drugs get filed together: one receptor, one sort of trip, one promise for depression, anxiety and addiction. In rats,…...


hollywoodtimes.net > west-hollywoods-newest-escape-the-rest-room-brings-mind-bending-sensory-floats-to-weho

West Hollywood???s Newest Escape: The Rest Room Brings Mind-Bending Sensory Floats to WeHo

1+ day, 9+ min ago   (186+ words) Whether you’re looking to spark creative artistic inspiration, reset an overworked brain, or simply experience a visually stunning, weightless journey, WeHo’s latest hotspot is officially open for business. The Pairing spatial audio, binaural beats, and dynamic light patterns with weightlessness…...


washingtonpost.com > health > 06/09/2025 > illegal-psychedelic-ibogaine-texas

Why Texas is spending millions to research an illegal psychedelic

1+ mon, 1+ day ago   (100+ words) Breaking news and analysis on politics, business, world, national news, entertainment and more. In-depth DC, Virginia, Maryland news coverage including traffic, weather, crime, education, restaurant reviews and more. Ibogaine is illegal in the United States, but Texas is on the…...


foxnews.com > video > 6404988313112

VA Secretary Doug Collins details fast-tracking of psychedelics for veterans with PTSD | Fox News Video

1+ day, 17+ hour ago   (68+ words) Veterans Affairs Secretary Doug Collins discusses the Trump administration’s efforts to fast-track the use of psychedelic drugs to help veterans struggling with PTSD on ‘The Big Weekend Show.’... VA Secretary Doug Collins details fast-tracking of psychedelics for veterans with PTSD…...